Awardee OrganizationCHILDREN'S HOSPITAL & RES CTR AT OAKLAND
Description
Abstract Text
DESCRIPTION (provided by applicant): K05 Senior Scientist Grant (NCCAM). Ames has published more than 450 publications and consistently ranks among the top few hundred of the most-cited-scientists in all fields; honors include The National Medal of Science & The Japan Prize. Career as pioneer/leader in: gene-regulation; genetic toxicology; mutagenesis; cancer prevention; endogenous oxidants/antioxidants; nutrition and health; mitochondrial decay; and aging. Professor of the Graduate School at U.C. Berkeley. Senior Scientist, Children's Hospital of Oakland Research Institute, with large lab in a newly renovated building. Scientific focus: ramifications of a major review showing that about 50 different human genetic diseases due to a poorer binding affinity (Km) of the mutant enzyme for the coenzyme, can be remedied by feeding high dose B vitamins which raise levels of the corresponding coenzyme; many polymorphisms also have lowered affinity of enzyme for coenzyme. We propose to expand this Km concept by: 1) Testing the effectiveness of high dose B vitamins on phenotypes caused by polymorphisms that affect the Km of enzymes for coenzyme, e.g. homocysteine accumulation in MTHFR: riboflavin; alcohol intolerance in half of Asians: niacin. 2) Testing the effectiveness of other metabolites and micronutrients.3) Determining if mitochondrial oxidative decay with age causes enzymes to lose affinity for their coenzymes and if this can be ameliorated by feeding high doses of B vitamins. Previous results showed that high doses of key mitochondrial metabolites delay mitochondrial decay and involve Km. 4) Minimizing DNA damage and cancer by optimizing micronutrient levels, particularly in the elderly.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AsiansDNA damageaerobiosisagingalcoholsclinical researchclinical trialscofactordosagedrug tolerancegenetic disordergenetic polymorphismhomocysteinehuman old age (65+)human subjecthuman therapy evaluationinborn metabolism disorderlongitudinal human studymitochondrial DNAmutantniacinnutrition related tagriboflavinvitamin B complexvitamin metabolismvitamin therapy
National Center for Complementary and Integrative Health
CFDA Code
213
DUNS Number
076536184
UEI
PMDEB5ZPQQN3
Project Start Date
01-January-2003
Project End Date
31-December-2005
Budget Start Date
01-January-2004
Budget End Date
31-December-2004
Project Funding Information for 2004
Total Funding
$256,875
Direct Costs
$237,847
Indirect Costs
$19,028
Year
Funding IC
FY Total Cost by IC
2004
National Center for Complementary and Integrative Health
$256,875
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K05AT001323-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K05AT001323-02
Patents
No Patents information available for 5K05AT001323-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K05AT001323-02
Clinical Studies
No Clinical Studies information available for 5K05AT001323-02
News and More
Related News Releases
No news release information available for 5K05AT001323-02
History
No Historical information available for 5K05AT001323-02
Similar Projects
No Similar Projects information available for 5K05AT001323-02